Home Cart 0 Sign in  
X

[ CAS No. 172023-97-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 172023-97-1
Chemical Structure| 172023-97-1
Chemical Structure| 172023-97-1
Structure of 172023-97-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 172023-97-1 ]

Related Doc. of [ 172023-97-1 ]

Alternatived Products of [ 172023-97-1 ]

Product Details of [ 172023-97-1 ]

CAS No. :172023-97-1 MDL No. :MFCD09835207
Formula : C8H6BrF3O Boiling Point : -
Linear Structure Formula :- InChI Key :MPYFWGBMAYFJOH-UHFFFAOYSA-N
M.W : 255.03 Pubchem ID :29919767
Synonyms :

Calculated chemistry of [ 172023-97-1 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.27
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.0 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.11
Log Po/w (XLOGP3) : 2.61
Log Po/w (WLOGP) : 3.96
Log Po/w (MLOGP) : 3.32
Log Po/w (SILICOS-IT) : 3.38
Consensus Log Po/w : 3.07

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.28
Solubility : 0.135 mg/ml ; 0.000531 mol/l
Class : Soluble
Log S (Ali) : -2.68
Solubility : 0.527 mg/ml ; 0.00207 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.97
Solubility : 0.0273 mg/ml ; 0.000107 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.73

Safety of [ 172023-97-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 172023-97-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 172023-97-1 ]
  • Downstream synthetic route of [ 172023-97-1 ]

[ 172023-97-1 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 537039-44-4 ]
  • [ 172023-97-1 ]
YieldReaction ConditionsOperation in experiment
69% With tert.-butylnitrite; copper(ll) bromide In acetonitrile at 65℃; for 0.5 h; (3-Bromo-5-(trifluoromethyl)phenyl)methanol. (3-Amino-5-(trifluoromethyl)phenyl)methanol (1.6 g, 8.4 mmol) in dry acetonitrile (10 mL) was added dropwise to a solution of copper (II) bromide (2.24 g, 10.0 mmol) and tert-butyl nitrite (1.48 mL, 12.0 mmol) in acetonitrile (20 mL) at 65° C. After stirring for 30 min at 65° C., the reaction mixture was cooled to room temperature, poured into a 1 N hydrochloric acid solution, and extracted with ethyl acetate (2.x.). The organic layers were pooled together, washed with brine (2.x.), dried over sodium sulfate, and concentrated. Column chromatography on silica gel (20percent ethyl acetate/hexanes) afforded 1.48 g (69percent). 1H-NMR (CDCl3, 500 MHz) δ 7.71 (s, 1H), 7.68 (s, 1H), 7.55 (s, 1H), 4.75 (s, 2H).
Reference: [1] Patent: US2007/249607, 2007, A1, . Location in patent: Page/Page column 62
[2] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3039 - 3043
[3] Patent: WO2007/88999, 2007, A1, . Location in patent: Page/Page column 164-165
[4] Patent: WO2007/116922, 2007, A1, . Location in patent: Page/Page column 54
[5] Patent: WO2005/100298, 2005, A1, . Location in patent: Page/Page column 65
  • 2
  • [ 328-67-6 ]
  • [ 172023-97-1 ]
YieldReaction ConditionsOperation in experiment
69%
Stage #1: With borane-THF In tetrahydrofuran at 65℃; for 2 h;
Stage #2: With water; sodium hydrogencarbonate In tetrahydrofuran
16). Synthesis of 1-bromomethyl-3-methanesulfonyl-5-trifluoromethyl-benzene; To a solution of 3-bromo-5-(trifluoromethyl)benzoic acid (5 mmol, 1.35 g) in THF (8 mL) is added 1M boran in THF (16 mmol, 16 ml_) under nitrogen. The solution is allowed to warm to 65 0C and stirred for 2 hours. The mixture is cooled to room temperature, then poured into saturated aq. NaHCO3. The mixture is extracted with EtOAc. The combined organic layer is washed with brine, dried over Na2SO4, filtrated, and concentrated under reduced pressure. The residue is purified by silica gel column chromatography (eluent: hexane / EtOAc) to give (3-bromo-5-trifluoromethyl-phenyl)-methanol (418 mg, 69percent).
57%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 20℃; for 20 h;
Stage #2: With methanol In tetrahydrofuran
Step C:
(3-Bromo-5-(trifluoromethyl)phenyl)methanol
To a solution of 3-bromo-5-(trifluoromethyl)benzoic acid (2.13 gm, 7.92 mmol) in anhydrous THF under nitrogen was added borane dimethylsulfide complex (15.83 mmol, 7.91 mL) and the mixture was stirred at room temperature for 16 hours.
A further aliquot of borane dimethylsulfide complex (15.83 mmol, 7.91 mL) was then added and stirring was continued at room temperature for a further 4 hours. LC-MS indicated complete consumption of starting material.
Methanol was added cautiously until effervescence ceased then 2N hydrochloric acid (20 mL) was added.
The mixture was stirred at room temperature for 20 hours then concentrated to dryness under reduced pressure.
The residue was extracted with diethyl ether and the solution washed with water.
The organic layer was dried with anhydrous sodium sulfate and the solvent removed under vacuum.
The residue was dissolved in a mixture of dichloromethane and methanol, silica gel was added and the solvent removed under vacuum.
The solid was placed on a column of silica gel (50 gm) and eluted with hexane-ethyl acetate (85:15) to give the title compound as a yellow oil which crystallized on standing (1.16 gm, 57percent).
LC-MS (ES-) Calc: 255, Found: 254 (M-H).
1H NMR (CDCl3) δ ppm 7.72 (brs, 1H), 7.69 (brs, 1H), 7.57 (brs, 1H), 4.77 (s, 2H), 1.86 (brs, 1H).
Reference: [1] Patent: WO2008/9435, 2008, A1, . Location in patent: Page/Page column 162
[2] Patent: US2007/213371, 2007, A1, . Location in patent: Page/Page column 71
[3] Patent: US2014/171403, 2014, A1, . Location in patent: Page/Page column
  • 3
  • [ 477535-41-4 ]
  • [ 172023-97-1 ]
Reference: [1] MedChemComm, 2017, vol. 8, # 5, p. 1121 - 1130
  • 4
  • [ 328-80-3 ]
  • [ 172023-97-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3039 - 3043
  • 5
  • [ 172023-97-1 ]
  • [ 477535-41-4 ]
Reference: [1] Patent: WO2005/100298, 2005, A1, . Location in patent: Page/Page column 65
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 172023-97-1 ]

Fluorinated Building Blocks

Chemical Structure| 497959-33-8

[ 497959-33-8 ]

2-Bromo-4-(trifluoromethyl)benzyl alcohol

Similarity: 0.92

Chemical Structure| 869725-53-1

[ 869725-53-1 ]

2-Bromo-5-(trifluoromethyl)benzyl Alcohol

Similarity: 0.90

Chemical Structure| 86845-28-5

[ 86845-28-5 ]

1-Bromo-3-methyl-5-(trifluoromethyl)benzene

Similarity: 0.87

Chemical Structure| 401-78-5

[ 401-78-5 ]

3-Bromobenzotrifluoride

Similarity: 0.87

Chemical Structure| 86845-27-4

[ 86845-27-4 ]

5-Bromo-2-methylbenzotrifluoride

Similarity: 0.87

Aryls

Chemical Structure| 497959-33-8

[ 497959-33-8 ]

2-Bromo-4-(trifluoromethyl)benzyl alcohol

Similarity: 0.92

Chemical Structure| 869725-53-1

[ 869725-53-1 ]

2-Bromo-5-(trifluoromethyl)benzyl Alcohol

Similarity: 0.90

Chemical Structure| 86845-28-5

[ 86845-28-5 ]

1-Bromo-3-methyl-5-(trifluoromethyl)benzene

Similarity: 0.87

Chemical Structure| 401-78-5

[ 401-78-5 ]

3-Bromobenzotrifluoride

Similarity: 0.87

Chemical Structure| 86845-27-4

[ 86845-27-4 ]

5-Bromo-2-methylbenzotrifluoride

Similarity: 0.87

Bromides

Chemical Structure| 497959-33-8

[ 497959-33-8 ]

2-Bromo-4-(trifluoromethyl)benzyl alcohol

Similarity: 0.92

Chemical Structure| 869725-53-1

[ 869725-53-1 ]

2-Bromo-5-(trifluoromethyl)benzyl Alcohol

Similarity: 0.90

Chemical Structure| 86845-28-5

[ 86845-28-5 ]

1-Bromo-3-methyl-5-(trifluoromethyl)benzene

Similarity: 0.87

Chemical Structure| 401-78-5

[ 401-78-5 ]

3-Bromobenzotrifluoride

Similarity: 0.87

Chemical Structure| 86845-27-4

[ 86845-27-4 ]

5-Bromo-2-methylbenzotrifluoride

Similarity: 0.87

Alcohols

Chemical Structure| 497959-33-8

[ 497959-33-8 ]

2-Bromo-4-(trifluoromethyl)benzyl alcohol

Similarity: 0.92

Chemical Structure| 869725-53-1

[ 869725-53-1 ]

2-Bromo-5-(trifluoromethyl)benzyl Alcohol

Similarity: 0.90

Chemical Structure| 349-75-7

[ 349-75-7 ]

(3-(Trifluoromethyl)phenyl)methanol

Similarity: 0.76

Chemical Structure| 349-95-1

[ 349-95-1 ]

(4-(Trifluoromethyl)phenyl)methanol

Similarity: 0.76

Chemical Structure| 346-06-5

[ 346-06-5 ]

(2-(Trifluoromethyl)phenyl)methanol

Similarity: 0.76

Trifluoromethyls

Chemical Structure| 497959-33-8

[ 497959-33-8 ]

2-Bromo-4-(trifluoromethyl)benzyl alcohol

Similarity: 0.92

Chemical Structure| 869725-53-1

[ 869725-53-1 ]

2-Bromo-5-(trifluoromethyl)benzyl Alcohol

Similarity: 0.90

Chemical Structure| 86845-28-5

[ 86845-28-5 ]

1-Bromo-3-methyl-5-(trifluoromethyl)benzene

Similarity: 0.87

Chemical Structure| 401-78-5

[ 401-78-5 ]

3-Bromobenzotrifluoride

Similarity: 0.87

Chemical Structure| 86845-27-4

[ 86845-27-4 ]

5-Bromo-2-methylbenzotrifluoride

Similarity: 0.87